The Patent Finder

Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS

Armagen, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 14/305,402, filed Jun 16, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,028,156Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
Armagen, Inc.In force
High confidence
US 8,834,874Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
JCR Pharmaceuticals Co., Ltd.In force
High confidence
US 12,043,661Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
Armagen, Inc.In force
High confidence
US 10,011,651Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
In force
 · High confidence
JCR Pharmaceuticals Co., Ltd.In force
High confidence
Application 18/740,035Methods and Compositions for Increasing Iduronate 2-Sulfate Activity in the CNS
Pending
Not granted
ArmaGen, Inc.PendingNot granted
Application 19/401,802Pharmaceutical Agents for Increasing Iduronate 2-Sulfatase Activity in the CNS
Pending
Not granted
Armagen Technologies, Inc.PendingNot granted
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Armagen, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited